Articles
The ‘supply chain’ patient is sick: is there a cure for the Pharma Supply Chain? (part 2)

The ‘supply chain’ patient is sick: is there a cure for the ...

In his concluding article Hedley Rees looks at the cure for the ‘sick’ pharmaceutical supply chain. Well, is there a treatment option? Yes, I would say there is, and the regulators certainly think so too, having been pressing the industry for nearly...

Articles
Where to now for UK life sciences?

Where to now for UK life sciences?

The 2012 UK Life Science Industry Leaders Survey highlights a concern that the UK is losing its position as a centre for global R&D. Nick Stephens presents results from the survey and draws out some themes that are relevant to the industry as a whole. The 2012 UK Life Science Industry Leaders Survey highlights a concern that the UK is losing its position as a centre for global R&D...

Articles
mHealth Monthly Mashup: Release 6.0 - The gamification of healthcare and what it means for mobile

mHealth Monthly Mashup: Release 6.0 - The gamification of h...

Checking in to his last instalment of the series for 2011, Michael Spitz discusses how gamification has impacted on mobile health. The rapid evolution of smartphones, app stores, and healthcare user behaviours has created an mHealth revolution, one so exponential in...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more